AZT-16142-68617
3 vaccinations
7 coded responses
33 check-ins
7 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 386 / MS
- Registered
- 2021-03-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-06
Dose 1 — Pfizer-BioNTech
-
2021-03-15
Registered in v-safe
-
2021-03-15
Health check-in — day 7, dose 1Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
- 2021-03-20
-
2021-03-27
Survey response — day 21, dose 1MedDRA: Headache — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Headache that has lasted 3 daysMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-29
Dose 2 — Pfizer-BioNTech
-
2021-03-30
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-31
- 2021-04-01
- 2021-04-02
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-12
-
2021-04-19
Survey response — day 21, dose 2MedDRA: Headache — Feeling: Good · Be unable to do your normal daily activitiesFree text: HeadacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-26
- 2021-05-03
- 2021-05-10
- 2021-06-28
- 2021-09-27
-
2021-12-09
Dose 3 — Pfizer-BioNTech
- 2021-12-09
-
2021-12-10
Health check-in — days 1–6 daily, dose 3Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-12-11
- 2021-12-12
- 2021-12-13
- 2021-12-14
- 2021-12-15
- 2021-12-16
- 2021-12-23
-
2021-12-30
Survey response — day 21, dose 3MedDRA: Rash, Rash pruritic, Sensitive skin — Feeling: GoodFree text: Very itchy rash on hip and chest. May or may not be related, I do have sensitive skin.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-06
Survey response — day 28, dose 3MedDRA: Pre-existing disease, Rash — Feeling: GoodFree text: Worsening rash. May or may not be related, I have sensitive skin.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-13
Survey response — day 35, dose 3MedDRA: Rash, SARS-CoV-2 test negative, Urticaria — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Worsening rash, large patches of hives. Prescribed Medrol which helped some but they have returned upon stopping Medrol. Several negative COVID tests.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-13
Report sent to call center — day 35, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-01-17
-
2022-01-20
Survey response — day 42, dose 3MedDRA: Urticaria — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Worsening hives that continue to spread. Have ruled out environmental cause. Did report to VAERSMedDRA releases: 2024-11 · check-in free text available
-
2022-01-20
Report sent to call center — day 42, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-01-22
- 2022-03-10
- 2022-06-09
-
2022-12-09
Survey response — 12 months, dose 3MedDRA: COVID-19, Office visit, Supraventricular tachycardia — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Symptoms: Diagnosed with Supraventricular Tachycardia- prior to first and only COVID infection · Healthcare visit (other): CardiologistMedDRA releases: 2024-11 · check-in free text available
-
2022-12-09
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2022-12-13
- 2022-12-13
- 2022-12-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-06 | Pfizer-BioNTech | |
| 2 | 2021-03-29 | Pfizer-BioNTech | |
| 3 | 2021-12-09 | Pfizer-BioNTech | No |
Call center
3 call center cases
3 unsuccessful
VAERS report filed, before or during a call: 3
Free text
Release 6 — day 21, dose 1
Symptoms: Headache that has lasted 3 days
Release 7 — day 21, dose 2
Symptoms: Headache
Release 10 — day 21, dose 3
Symptoms: Very itchy rash on hip and chest. May or may not be related, I do have sensitive skin.
Release 10 — day 28, dose 3
Symptoms: Worsening rash. May or may not be related, I have sensitive skin.
Release 10 — day 35, dose 3
Symptoms: Worsening rash, large patches of hives. Prescribed Medrol which helped some but they have returned upon stopping Medrol. Several negative COVID tests.
Release 10 — day 42, dose 3
Symptoms: Worsening hives that continue to spread. Have ruled out environmental cause. Did report to VAERS
Release 12 — 12 months, dose 3
Symptoms: Diagnosed with Supraventricular Tachycardia- prior to first and only COVID infection
Healthcare visit (other): Cardiologist
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Rash pruritic | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Sensitive skin | · | · | ✓ |
| SD | Supraventricular tachycardia | · | · | ✓ |
| SD | Urticaria | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release